Formononetin

DB15335ExperimentalSmall molecule

Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).

Chemical structure of Formononetin
Formula / weight
C16H12O4 · 268.268 g/mol (avg)

Resolves to

Compound
UNII295DQC67BJCAS485-72-3ChEMBLCHEMBL242341ChEBI18088KEGGC00858
Structure
InChIKeyHKQYGTCOTHHOMP-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C1=COC2=C(C=CC(O)=C2)C1=O
Targets
P31639SLC5A2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
557Drug interactionsStructured to mechanism, not free text
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Formononetin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In